Our plain-English summary of Etiology of specific molecular alterations in human malignancies, by H. Vauhkonen, S. Heino, S. Myllykangas, et al (Cytogenetic and Genome Research, 2007).
You don't need the product names or old records. No fee unless we recover compensation for your family.
The study
- Authors: H. Vauhkonen, S. Heino, S. Myllykangas, P.M. Lindholm, S. Savola, S. Knuutila
- Journal: Cytogenetic and Genome Research
- Published: 2007;118(2-4):277-83
- Type of article: Review
- Cited by: 5 articles, as counted by NIH iCite
- Read it: PubMed · Publisher
Abstract
Cancer results from multiple genomic changes that affect DNA and its gene expression. The DNA sequences may be gained, lost or amplified, or translocated into different parts of the genome to form a fusion gene with oncogenic properties. The occurrence of specific chromosomal aberrations may be restricted to only one cancer type and it may be considered a primary carcinogenic event. Furthermore, the aberration profiles may be used to cluster tumors with similar origins. A variety of techniques exist for the detection of specific chromosomal and gene expression changes. However, the etiology of these molecular alterations remains unclear. Here we discuss the roles of Helicobacter pylori and asbestos burden as carcinogens that cause gastric cancer, mesothelioma and lung cancer.
Copyright (c) 2007 S. Karger AG, Basel.
In plain English
This article was a review, not an original study. The authors discussed published research on chromosome and gene changes in cancer, the laboratory methods used to detect them, and the roles of Helicobacter pylori infection and asbestos exposure as causes of gastric cancer, mesothelioma and lung cancer. They described asbestos exposure as known to predispose to mesothelioma, to be involved in lung cancer, and to have an additive effect with smoking in asbestos-related lung cancer. They noted that, in cell lines and laboratory exposure experiments, asbestos had been shown to cause chromosome aberrations and to disrupt cell division. They cited a 2006 study by Nymark and colleagues that described asbestos-related regions of DNA copy number change linked to fragile sites in the genome. They also noted that SV40 virus has been implicated as a cofactor in mesothelioma but that its role was still unclear. The authors wrote that the first events in mesothelial and gastric cancer development remained largely unknown. They concluded that microarray methods offered a way to model how tumors linked to outside agents progress.
We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.
What the study did and found
- Design: Review (discussion of published research); no new data were collected
- Who was studied: No patients, workers or samples were studied. The article discussed published studies on gastric cancer, mesothelioma and lung cancer, and on cell lines and laboratory exposure experiments.
- Exposure: Asbestos exposure ("asbestos burden") and Helicobacter pylori infection, discussed as carcinogens. The text did not discuss specific fiber types.
- Main results:
- The authors described asbestos exposure, citing earlier studies, as causing an additive effect together with smoking in asbestos-related lung cancer.
- The authors described gastric and mesothelial cancer development as sharing features, including being caused by an agent that induces chronic inflammation (H. pylori and asbestos).
- The authors reported that H. pylori infection and asbestos exposure had been described as causing similar cellular responses, including activation of the nuclear factor kB and mitogen activated protein kinase pathways.
- Citing cell line and laboratory exposure studies, the authors reported that asbestos had been shown to cause chromosome aberrations, disrupt cell division (mitosis) and block chromosome segregation.
- The authors cited Nymark et al. (2006) as having published asbestos-related regions of DNA copy number change, and reported that these regions had been shown to be associated with genomic fragile sites.
- The authors noted that Simian virus 40 (SV40) had been implicated as a cofactor in asbestos-related malignant mesothelioma, but that its role in how mesothelioma develops was still unclear.
- A reproduced table listed loss of DNA copy number on chromosomes 10 and 14 ("dim(10,14)") in mesothelioma as a feature distinguishing mesothelioma from adenocarcinoma of the lung.
- The authors wrote that the primary events in mesothelial and gastric cancer development remained largely unknown.
- The authors' conclusion: The authors concluded that microarray methods and a systems biology approach made it possible, for the first time, to design a model of how tumors associated with exposure to outside agents progress. They added that the methods described could also be used to investigate mutagenic processes.
Topics
Medical terms in this study, explained in our Lexicon: Etiology, Carcinogenic, Stomach Cancer, Mesothelioma, Lung Cancer.
Related studies
- Correlations between chemically related site-specific carcinogenic effects in long-term studies in rats and mice — J.K. Haseman, A.M. Lockhart (1993)
- Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma — S.S. Murthy, J.R. Testa (1999)
- Unique Cellular and Biochemical Features of Human Mitochondrial Peroxiredoxin 3 Establish the Molecular Basis for Its Specific Reaction with Thiostrepton — K.J. Nelson, T. Messier, et al. (2021)
- Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity — M.K. Kaneko, S. Yamada, et al. (2017)
- DNA methylation status of REIC/Dkk-3 gene in human malignancies — T. Hayashi, H. Asano, et al. (2012)
- Implications of multiple mechanisms of carcinogenesis for short-term testing — B.L. Harper, D.L. Morris (1984)
Browse return to medical research.
Cited on this site
How to cite it
Cite the study
H. Vauhkonen, S. Heino, S. Myllykangas, P.M. Lindholm, S. Savola, S. Knuutila. Etiology of specific molecular alterations in human malignancies. Cytogenetic and Genome Research 2007;118(2-4):277-83. doi:10.1159/000108311. PMID: 18000381.
Cite our summary
“Etiology of specific molecular alterations in human malignancies.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/etiology-of-specific-molecular-alterations-in-human-malignancies.
ACL Doc numbers and their short links never change. See how to cite the Library.
Talk with an asbestos lawyer
Start with what you remember, and we'll take it from there.
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.